Nonalcoholic Steatohepatitis Completed Phase 2 Trials for Cenicriviroc (DB11758)

IndicationStatusPhase
DBCOND0029353 (Nonalcoholic Steatohepatitis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02217475Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Participants With Liver FibrosisTreatment